The FDA approves Medtronic's (MDT +0.1%) Advisa DR MRI SureScan pacing system, the company's...

|About: Medtronic plc (MDT)|By:, SA News Editor

The FDA approves Medtronic's (MDT +0.1%) Advisa DR MRI SureScan pacing system, the company's next-generation pacemaker that enables patients to receive MRI scans, something that is not allowed with traditional pacemakers. It's worth noting that up to 75% of patients with implanted heart devices worldwide are expected to need an MRI scan during the lifetime of those devices. (PR)